Insulet
PODD
#2102
Rank
NZ$16.82 B
Marketcap
NZ$242.65
Share price
1.19%
Change (1 day)
-52.72%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2026 (TTM): NZ$5.80

According to Insulet's latest financial reports the company's current EPS (TTM) is NZ$5.71. In 2024 the company made an earnings per share (EPS) of NZ$10.16 an increase over its 2023 EPS that were of NZ$5.01.

EPS history for Insulet from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$5.80
2024NZ$10.16102.71%
2023NZ$5.014114.29%
2022NZ$0.12-69.57%
2021NZ$0.39109.09%
2020NZ$0.19-38.89%
2019NZ$0.31200%
2018NZ$0.10-113.04%
2017NZ-$0.78-9.8%
2016NZ-$0.87-60.47%
2015NZ-$2.1938.71%
2014NZ-$1.5812.05%
2013NZ-$1.41-23.15%
2012NZ-$1.83-12.2%
2011NZ-$2.09

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.84 159.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.13 7.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.35 11.31%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$47.94 740.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
NZ-$2.38-141.67%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
NZ$3.18-44.35%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$4.08-28.57%๐Ÿ‡บ๐Ÿ‡ธ USA